DBP B — Double Bond Pharmaceutical International AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK26.57m
- SEK25.51m
- SEK0.08m
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University
Brief: DBP International Extends Deal With Unitechprom And Research Institute
Brief: Double Bond Pharmaceutical International Unit Gets Order From Apotek365
Brief: DBP Reports In Vivo Proof-Of-Concept Study Of SI-053 Was Successfully Finished
Brief: DBP International Gets US Patent For Temodex / SI-053
Brief: DBP International Q2 Operating Loss Widens To SEK 2.8 Mln
Brief: Double Bond Pharmaceutical International Unit Farmpharma Gets Subsidy Of SEK 0.3 Million From Vinnova
Brief: DBP Q1 Oper Loss Widens To SEK 4.3 Mln
Brief: Double Bond Pharmaceutical International Postpones AGM
Brief: DBP Unit Drugsson Gets Order Of SEK 0.2 Mln
Brief: Double Bond Pharmaceutical International Carries Out New Directed Share Issue Of About SEK 15.5 Mln
Brief: DBP International Q4 Operating Loss Narrows To SEK 1.4 Mln
Brief: DBP International Gets European Patent For Temodex / SI-053
Brief: DBP International Carries Out Rights Issue Of About SEK 15 Mln
Brief: Double Bond Pharmaceutical Unit FarmPharma Signs Agreement With Karolinska Institutet
Brief: Double Bond Pharmaceutical Seeks Patent For Iron Succinate